Surgery News and Research

RSS

Lake Health opens TriPoint Medical Center in Concord Township

Lake Health, formerly Lake Hospital System, today is celebrating the grand opening of its $155 million TriPoint Medical Center in Concord Township. A state-of-the-art digital hospital, TriPoint Medical Center is redefining the health care experience for patients, families and the community.

22 Oct 2009

OR Benchmarks Collaborative names the 2009 Top Performers

Faced with today’s unrelenting financial demands and quality of care challenges, leading hospitals and ambulatory surgery centers are turning to comparative healthcare benchmarks to help them improve operating room (OR) performance. Six of these trailblazers have been recognized by one such service, the OR Benchmarks® Collaborative (ORBC), as 2009 Top Performers that have used ORBC data to achieve significant results.

21 Oct 2009

Lux Biosciences to present on LX211 at 2009 AAO annual conference

Lux Biosciences, Inc., a privately held biotechnology company focused on the development and commercialization of therapies for serious ophthalmic diseases, today announced that the company’s experimental drug LX211 (LUVENIQ; oral voclosporin) will be featured in several presentations at the 2009 American Academy of Ophthalmology annual conference and American Uveitis Society meeting being held October 24-26 in San Francisco.

21 Oct 2009

Northwest Biotherapeutics announces long-term data from Phase I and Phase I/II clinical trials of DCVax-Brain

Northwest Biotherapeutics, Inc. today announced further long-term follow-up data, for the period from January through September 2009, from its prior Phase I and Phase I/II clinical trials conducted at UCLA with DCVax®-Brain in patients with Glioblastoma multiforme ("GBM"). GBM is the most rapid and lethal type of brain cancer. During the update period, only one of the twenty patients treated with DCVax®-Brain (in addition to standard of care) died, and that patient had survived for nearly 7 years (80.5 months).

21 Oct 2009

Markers that cause primary liver cancer identified

Hepatocellular carcinoma (HCC) or primary liver cancer forms in the epithelial tissue of the liver and is most commonly caused by the hepatitis B virus (HBV) or hepatitis C virus (HCV). In the U.S., the National Cancer Institute (NCI) estimates that 15,000 men and 6,000 women are diagnosed with HCC each year.

21 Oct 2009

Case Western Reserve University Biomedical Engineering Department to celebrate its 40th anniversary

The Case Western Reserve University Biomedical Engineering Department has set trends for academia and launched medical inventions benefiting newborns and the aged, the critically ill and traumatically injured. The department will reflect and look to the future as it celebrates its 40th anniversary, Thursday, Oct. 22.

21 Oct 2009

Philadelphia's Franklin Institute to exhibit Gunther von Hagens' Body Worlds 2 & The Brain

Gunther von Hagens' Body Worlds 2 & The Brain made its debut at Philadelphia's Franklin Institute on October 17, and will be one of many points of interest for visitors eager to explore the area's vast array of scientific treasures.

21 Oct 2009

MUSC launches Social Media Newsroom for real-time information on medical news and research

As the editorial landscape continues to evolve with the emergence of social media, many people struggle to find trusted resources that offer accurate, real time information related to healthcare news and research.

21 Oct 2009

MIRP surgery carries higher risk of impotence and incontinence than traditional surgery

A new study debating the effectiveness of minimally invasive prostate surgery is not telling the whole story, warns Dr. David B. Samadi, Chief of the Division of Robotics and Minimally Invasive Surgery in the Department of Urology at The Mount Sinai Medical Center in New York.

21 Oct 2009

New tools needed to identify men and women at risk for the most aggressive cancers

Twenty years of screening for breast and prostate cancer - the most diagnosed cancer for women and men - have not brought the anticipated decline in deaths from these diseases, argue experts from the University of California, San Francisco and the University of Texas Health Science Center at San Antonio in an opinion piece published in the "Journal of the American Medical Association."

21 Oct 2009

UF scientists shed new light on old medical procedure

You might not know what it's called, but if you've had general anesthesia before surgery, especially after an accident, it is likely you have received Sellick's maneuver. That's when fingers are pressed against a patient's throat to prevent regurgitation and spilling of stomach contents into the airway and lungs while anesthesia is being administered.

21 Oct 2009

Amputation prevention tips for diabetic patients

While "One Foot, Two Foot, Red Foot, Blue Foot" may be the opening line of a humorous children's book by Dr. Seuss, foot complications are no laughing matter to the 20 million Americans with diabetes. According to the American Orthopaedic Foot & Ankle Society (AOFAS), ulceration, infection, and gangrene are the most common foot and ankle problems of the diabetic patient.

21 Oct 2009

Duke Abdominal Assessment Scale can help predict NEC disease in newborns

Radiologists at Duke University Medical Center have developed a scale called the Duke Abdominal Assessment Scale (DAAS) to assist clinicians in determining the severity of disease and the need for surgery in infants with necrotizing enterocolitis (NEC), according to a study in the November issue of the American Journal of Roentgenology.

21 Oct 2009

MediWound reports positive results from phase III Debrase trial for treating burns

Teva Pharmaceutical Industries Ltd. announced today that MediWound Ltd., a company in which Teva holds an 11% interest, reported positive results from a pre planned interim analysis of a phase III trial for Debrase®, an enzymatic debriding agent for burns.

21 Oct 2009

New cutting edge nerve procedure relieves migraine permanently

The Plastic Surgery Center today announced that a 57-year-old Plainfield man reports he is free of constant headache pain after undergoing a new cutting edge nerve procedure to permanently eliminate pain caused by migraines. The procedure was performed by plastic and reconstructive surgeon Dr. Matthew Kaufman, of the Plastic Surgery Center in New Jersey on August 4, 2009.

21 Oct 2009

Eclipsys supports healthcare providers to meet the goal of ARRA

To support healthcare organizations in making the appropriate technology decisions to maximize federal stimulus dollar opportunity, Eclipsys Corporation®, The Outcomes Company®, today announced the multiple superior outcomes its client organizations are achieving today.

20 Oct 2009

ImPACKD calls for raising awareness about the risks of calcium overuse in CKD patients

Most Canadians living with CKD have likely never spoken with their physicians about calcium and the serious health risks associated with its overuse. This is why Improving Patient Advocacy in Chronic Kidney Disease (ImPACKD), a group of CKD patients and caregivers committed to raising awareness about the risks of calcium overuse, is starting the conversation about the importance of knowing the limits and keeping them in check.

20 Oct 2009

Vertos Medical raises $15.5 million for U.S. commercialization of the company’s "mild" technology

Medical device company Vertos Medical, Inc., developer of the mild® procedure for lumbar spinal stenosis (LSS), today announced it has completed a $15.5 million Series D financing. New investor, ONSET Ventures, led the round with additional participation from existing Vertos investors CHL Medical Partners, Foundation Medical Partners, Aweida Venture Partners and DFJ Mercury.

20 Oct 2009

Aspect Medical Systems to present a complete family of BIS monitoring technologies at ASA meeting

The American Society of Anesthesiologists (ASA) Annual Meeting will feature 62 scientific presentations that reference BIS® monitoring when it convenes on October 17-21, 2009 in New Orleans. BIS-related research will cover a broad range of applications for BIS monitoring, including initial results from studies conducted as part of a comparative effectiveness research collaboration with the Cleveland Clinic as well as findings from a study evaluating use of a Composite Variability Index (CVI) that is based on BIS parameters.

20 Oct 2009

Two high blood pressure medicines effective in treating stable ischemic heart disease

Two medications commonly used to treat high blood pressure appear to be effective in treating a common type of heart disease known as stable ischemic heart disease, according to a new comparative effectiveness review funded by HHS' Agency for Healthcare Research and Quality.

20 Oct 2009

Surgery News and Research

Lake Health opens TriPoint Medical Center in Concord Township

OR Benchmarks Collaborative names the 2009 Top Performers

Lux Biosciences to present on LX211 at 2009 AAO annual conference

Northwest Biotherapeutics announces long-term data from Phase I and Phase I/II clinical trials of DCVax-Brain

Markers that cause primary liver cancer identified

Case Western Reserve University Biomedical Engineering Department to celebrate its 40th anniversary

Philadelphia's Franklin Institute to exhibit Gunther von Hagens' Body Worlds 2 & The Brain

MUSC launches Social Media Newsroom for real-time information on medical news and research

MIRP surgery carries higher risk of impotence and incontinence than traditional surgery

New tools needed to identify men and women at risk for the most aggressive cancers

UF scientists shed new light on old medical procedure

Amputation prevention tips for diabetic patients

Duke Abdominal Assessment Scale can help predict NEC disease in newborns

MediWound reports positive results from phase III Debrase trial for treating burns

New cutting edge nerve procedure relieves migraine permanently

Eclipsys supports healthcare providers to meet the goal of ARRA

ImPACKD calls for raising awareness about the risks of calcium overuse in CKD patients

Vertos Medical raises $15.5 million for U.S. commercialization of the company’s "mild" technology

Aspect Medical Systems to present a complete family of BIS monitoring technologies at ASA meeting

Two high blood pressure medicines effective in treating stable ischemic heart disease

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News